Table 2 |
|||
|
Transcription factors with significant target overlap to WT1 |
|||
|
TF |
Hypergeometric p-value |
# of genes overlapped |
Selected KEGG Pathways of targets shared with Wt1 |
|
|
|||
|
GLI1 |
0 |
36 |
MapK Signalling, Tight Junction, Focal Adhesion |
|
MEF2A |
0 |
29 |
MapK Signalling, Regulation of Actin Cytoskeleton |
|
NFIC |
0 |
16 |
MapK Signalling, Regulation of Actin Cytoskeleton, Insulin Signalling |
|
E2F |
2.0e-12 |
52 |
Calcium Signaling, Notch Signalling, Regulation of Actin Cytoskeleton, WNT Signalling |
|
SRF |
1.3e-10 |
11 |
MapK Signalling |
|
POU5F1 |
6.2e-10 |
38 |
Neuroactive Ligand Receptor Interaction, MapK Signalling |
|
YY1 |
3.8e-6 |
6 |
MapK Signalling, Regulation of Actin Cytoskeleton |
|
SPI1 |
1.1e-3 |
4 |
-- |
|
NANOG |
6.7e-3 |
23 |
MapK Signalling, Regulation of Actin Cytoskeleton |
|
POU1F1 |
7.7e-3 |
1 |
- |
|
CEBPB |
1.1e-2 |
6 |
Neuroactive Ligand Receptor Interaction |
|
GATA1 |
1.5e-2 |
3 |
MapK Signalling, Regulation of Actin Cytoskeleton |
|
T3R |
1.9e-2 |
2 |
MapK Signalling |
|
|
|||
|
TFs that have been determined to have significant regulatory overlap to WT1 are given. The p-value for the significance of the overlap as calculated by hypergeometric test is given in column 2. Column 3 lists the number of genes regulated by WT1 and the TF listed in each row. Column 4 lists a selection of the most common pathways in which the targets fall. |
|||
|
Holloway et al. Biology Direct 2008 3:24 doi:10.1186/1745-6150-3-24 |
|||